Differentiating JAK Inhibitors From Other Therapies in AD :

Expert dermatologists discuss the factors that differentiate JAK inhibitors from other AD therapies, highlighting itch scores as they relate to quality of life.

Related Keywords

United Kingdom , British , Lisa Swanson , Alexandra Golant , Christopher Bunick , , Peter Lio , British Journal , Biologics , Jak Inhibitors , Atopic Dermatitis , Mechanism Of Action , Quality Of Life , Pitch , Easi 70 , Easi 90 , Systemic ,